RecallDepth
Class II Ongoing

Tizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottles (NDC: 68788-7781-3), c) 60-count bottles, (NDC: 68788-7781-6), d) 90-count bottles (NDC: 68788-7781-9), e) 120-count bottles (NDC: 68788-7781-8), Rx only, Mfg: Dr. Reddy's Laboratories Limited.

Company
Preferred Pharmaceuticals, Inc.
Recall Initiated
June 26, 2023
Posted
July 12, 2023
Recall Number
D-0894-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
541 Bottles
Firm Location
Anaheim, CA, United States

Reason for Recall

Failed Stability Specifications

Distribution

Nationwide within the United States

Lot / Code Info

Lot#: a) H1621S, Exp: 12/31/2023; b) H2321C, Exp: 12/31/2023; c) H0421B, Exp: 12/31/2023; d) H1721E, H1921T, H3121M, Exp: 12/31/2023, e) H2021G, Exp: 12/31/2023

More recalls by Preferred Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class II Drug recalls